References
- 1. Zandberg DP, Bhargava R, Badin S, Cullen KJ. The role of human papillomavirus in nongenital cancers. CA Cancer J Clin. 2013;63(1):57-81. DOI: 10.3322/caac.21167.
- 2. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294-301. DOI: 10.1200/JCO.2011.36.4593.
- 3. Kadaja M, Isok-Paas H, Laos T, Ustav E, Ustav M. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog. 2009;5(4):e1000397. DOI: 10.1371/journal.ppat.1000397.
- 4. Centers for Disease Control and Prevention. Cancers associated with Human Papillomavirus (HPV). [Internet]. Available from: https://www.cdc.gov/cancer/hpv/basic_info/cancers.htm#ref.
- 5. Lawson W, Schlecht NF, Brandwein-Gensler M. The role of the Human Papillomavirus in the pathogenesis of schneiderian inverted papillomas: An analytic overview of the evidence. Head Neck Pathol. 2008;2(2):49-59. DOI: 10.1007/s12105-008-0048-3.
- 6. Sbrana MF, Borges RFR, Pinna FR, Neto DB. Voegels RL. Sinonasal inverted papilloma: rate of recurrence and malignant transformation in 44 operated patients. Braz J Otorhinolaryngol. 2021;87(1):80-4. DOI: 10.1016/j.bjorl.2019.07.003.
- 7. Bailey HH, Chuang LT, duPont NC, Eng C, Foxhall LE, Merrill JK, et al. American Society of Clinical Oncology statement: Human Papillomavirus vaccination for cancer prevention. J Clin Oncol. 2016:34(15):1803-12. DOI: 10.1200/JCO.2016.67.2014.